Moderator
Jagadeswara Rao Earla, MBA, PharmD, PhD, Merck & Co. Inc, Rahway, NJ, United States
This tour will take place during Poster Session 1, Posters will be hung from 10:30 AM - 1:30 PM.
Posters featured in this tour:
PT1: RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
PT2: EVIDENCE-BASED PICO MAPPING FOR EU JOINT CLINICAL ASSESSMENT (JCA) USING A REAL-TIME AI-ASSISTEDLIVINGSYSTEMATIC LITERATURE REVIEW (REAL-SLR): AN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CASE STUDY
PT3: ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
PT4: INTEGRATING MEDICINES AND MEDICAL SERVICES IN REAL-WORLD VALUE ASSESSMENT: EVIDENCE FROM SUBCUTANEOUS ONCOLOGY FORMULATIONS IN A DAY CARE SETTING
PT5: REAL WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS BY LINE OF THERAPY IN THE UNITED STATES
PT6: TARGETED THERAPY, IMMUNOTHERAPY, AND MOLECULAR TESTING IN ADVANCED SOLID TUMORS: A 2021-2025 MEDICARE ANALYSIS